University of Lynchburg

Digital Showcase @ University of Lynchburg
Undergraduate Theses and Capstone Projects
Spring 5-2020

Dose response effect of Mycobacterium smegmatis-derived
lipomannan in RAW 264.7 murine macrophages
Cassandra Robertson

Follow this and additional works at: https://digitalshowcase.lynchburg.edu/utcp
Part of the Biochemistry, Biophysics, and Structural Biology Commons, Biomedical Engineering and
Bioengineering Commons, and the Chemistry Commons

Dose response effect of Mycobacterium smegmatis-derived lipoarabinomannan on
RAW 264.7 murine macrophages
Cassandra Robertson
Senior Honors Project

Submitted in partial fulfillment of the graduation requirements of the
Westover Honors College
Westover Honors College
University of Lynchburg
May 2020

_________________________________________________
Dr. David Freier

_________________________________________________
Professor Jeremy Craft

_________________________________________________
Dr. Nancy Cowden

1
ABSTRACT
Tuberculosis is a debilitating respiratory disease caused by the bacterial species
Mycobacterium tuberculosis, which acts by infecting the host’s macrophages and evading their
immune responses. The purpose of the study was to determine if RAW 264.7 murine
macrophage activity could be facilitated and intensified by stimulation with LAM from M.
smegmatis.Stimulation with bacterial LAM, and lipopolysaccharide (LPS) as a positive control,
yields functional endpoints: nitric oxide (NO) production measured by nitrites (NO2) in the
culture supernatant and expression of proteins, such as tumor necrosis factor-α and inducible
nitric oxide synthase (iNOS). RAW 264.7 cells were stimulated dose-responsively with LAM at
concentrations of 1-1000 ng/mL. Use of 100 ng/mL LPS served as a positive control. Nitrite, an
indirect product of the NO inflammatory response, was measured by the Greiss reaction and total
protein was collected from the cells for western blotting to quantify iNOS. Preliminary results in
experiment one showed that LAM NO production was minimally noticeable in the 1000 ng/mL
dose and was still substantially lower than the LPS control when evaluated by the Greiss Assay.
Experiments two and three were conducted with higher doses of Lam, 3000 ng/mL and 5000
ng/mL and showed an increased response. The nitrite concentration reached by both these LAM
treatments still did not reach that of 100 ng/mL LPS. This result suggests that the pattern
recognition difference between Toll-like receptor-2 (TLR-2) for LAM and Toll-like receptor-4
(TLR-4) for LPS has an impact on the output of NO.
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INTRODUCTION
While the COVID-19 outbreak far overshadowed many significant anniversaries in the
early part of 2020, the CDC annually recognizes March 24thas World TB Day. It marks the
discovery of Mycobacterium tuberculosis, the bacterial species that causes the disease, by Dr.
Robert Koch in 1882 (CDC 2016). This anniversary, though not a celebration, is a day for
recognition of the infection that has been wreaking havoc on human populations for thousands of
years. Tuberculosis (TB), historically referred to as scrofula, the White Plague, and consumption,
is a respiratory disease and is transmittable from person to person via droplets from the sneezes
or coughs of an actively infected individual (Tuberculosis 2018). The 2019 World Health
Organization (WHO) TB report indicated that in 2018, there was a global estimate of 10 million
people diagnosed with the illness and nearly 1.5 million deaths (WHO 2019). Caused by
Mycobacterium tuberculosis (Mtb), this disease has evolved to be multi-drug resistant (MDR)
and requires a grueling six-month course of antibiotics to cure. Health and research professionals
often wonder how the ancient bacterial illness can still be so difficult to eradicate. The durability
of the pathogen can be attributed to the presence of persister cells, a dormant variant of a normal
cell that is slow growing and resistant to even high levels of antibiotics (Lewis 2010). These cells
likely evolved as an adaptation from competing with the human immune system (Lougheed
2017). Since these cells make the infection particularly impervious, it is crucial to research and
develop techniques that may improve the treatment process to more efficiently and effectively
eliminate TB. This requires a thorough understanding of the pathways in which TB infects its
host and how those mechanisms may be manipulated to weaken the bacteria.
In 2018 the WHO estimated that nearly one third of the world’s population carries
tuberculosis and that ten percent of those will acquire the infection, becoming a vector of the
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disease. While these numbers seem underwhelming, an estimated 10.4 million new cases, 1.7
million being fatal, arose in 2016 (Tuberculosis 2018). The disease, caused by Mtb bacterial
infection, often manifests as a respiratory infection but can also cause extrapulmonary disease to
organ systems such as in lymph node TB, skeletal TB, and genitourinary TB (Fanning 1999).
The disease is particularly virulent in those who become immunocompromised through age,
another disease, or otherwise. In addition, many individuals with the infection have a latent form
that may take years to unexpectedly activate. These factors lead to a bacterial contagion that
aggressively eludes the human immune system and many modern treatment attempts.
Pathogens have individual characteristics that determine their virulence by impacting
their hosts in unique ways. The distinguishing feature that heavily contributes to resilience is
their defensive outer layer. The cell envelope of Gram-positive bacteria is composed of an inner
membrane, phospholipid bilayer, surrounded by a thick layer of peptidoglycan that makes up the
rigid cell wall (Salton and Kim 1996). In contrast, Gram-negative bacteria have a very thin layer
of peptidoglycan separated from the inner membrane by periplasm and surrounded by another
phospholipid bilayer, the outer membrane (Fig. 1). Gram-negative bacteria also contain
lipopolysaccharide (LPS). Embedded in the outer membrane, the molecule activates the host
immune system and acts as an endotoxin when the bacterial cell is attacked. Mycobacteria often
resemble Gram-negative bacteria given the complexity of the cellular envelope; however, they
possess a capsule instead of an outer membrane and some of their internal components are
characteristic of only mycobacteria (Fig. 2). Lipomannan (LM) and lipoarabinomannan (LAM)
are examples of essential compounds of the mycobacterial cell envelope, though their exact
structural roles remain unclear (Fukuda et al. 2013).
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Figure 1: Comparison of the Gram-negative (left) and Gram-positive (right) cell envelopes.
Gram-negative cells contain an inner membrane, a periplasmic space, a thin peptidoglycan layer,
dense lipoproteins, and an outer membrane. Gram-positive bacteria contain an inner membrane
and a thick wall of peptidoglycan (Salton and Kim 1996).
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Figure 2: Diagram of a mycobacterial cell envelope. Layer from inside to out are inner
membrane, peptidoglycan and arabinoglycan, mycolic acids and extractable lipids, and a capsule.
LAM is anchored in the inner membrane and extends through the layers toward the capsule
(Abdallah 2007).
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Various proteins and polysaccharides contribute to the pathogenicity of mycobacterial species
and especially serve as a physical barrier to host defensive processes.
When the human immune system comes into contact with foreign particles, there are a
number of primary responders that identify whether or not the particle is a threat. When the
innate immune system recognizes signature proteins in pathogens, such as LPS or LAM, the
attack and elimination of the intruder begins. The macrophage is an important phagocyte, a cell
type that engulfs foreign particles, and an initial responder in the innate immune system.
Invaders are taken up as the cell membrane of the macrophage reaches around the particle,
forming a pocket called a phagosome. Under normal operation, this phagosome containing
harmful bacteria would be fused with a lysosome, releasing chemicals to destroy the bacteria
(Slonczewski and Foster 2017). One of these chemicals is nitric oxide (NO), released by a
protein called inducible nitric oxide synthase (iNOS). NO is responsible for killing many
intracellular organisms, including some mycobacteria (Park et al. 2000). Though different
species of microbes are vastly diverse in structure, there are a few common structural
components such as LPS in Gram-negative bacteria, peptidoglycan in Gram-positive bacteria,
and LAM in mycobacteria (Takeuchi and Akira 2001). These fundamental units activate the
host’s innate immune system and facilitate response to the pathogen.
Macrophages have many types of receptors through which mycobacterial particles bind,
inducing the maturation of the phagosome (Daffé and Reyrat 2008). One example is the mannose
receptor (MR). When TB comes in contact with the human immune system, mannose-capped
LAM interacts with the MR on the surface of the macrophage, initiating the phagocytosis of Mtb.
This specific activation of the MR from Mtbnegatively impacts the development of the
phagosome, reducing the capacity for phagolysosomal fusion (Daffé and Reyrat 2008). Toll-like
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receptors (TLRs) also exist on the surface of phagocytic cells and upon reception of a recognized
molecule, release pro-inflammatory cytokines. These substances, such as interleukin-1 (IL-1),
interleukin-12 (IL-12), and tumor necrosis factor-α (TNF-α) mediate the inflammatory process
and aid other immunological cells in their response to the invader (Dinarello 2000). LAM
modulates the host immune system by preventing the release of pro-inflammatory cytokines
IL-12 and TNF-α (Daffé and Reyrat 2008). The molecules aid leukocytes in adhering to
endothelial cells before emigrating to tackle the infection (Dinarello 2000). Without these
signaling molecules, other immune cells are not alerted to the presence of the disease and the
immune response does not achieve maximum efficiency.
It is still largely unknown how Mtbevades the cytocidal properties of macrophages. In
order to effectively target the disease, it is crucial to understand the pathway it takes to infect its
host. While TLR-4 is responsible for recognition of LPS and the stimulation of iNOS to produce
NO, there is evidence that LAM interacts with macrophages through TLR-2 (Takeuchi and Akira
2001). This difference could be responsible for the ability of Mtbto resist lysosomal degradation
inside the phagocyte. One potential research avenue is to investigate the role of TLR-2 as Mtb
evades the immune system. A second line of study is needed for better understanding of the
stimulatory effects of mycobacterial LAM on macrophages. Previous research indicates that
there are significant differences in the levels of response triggered by treatment of macrophages
with LPS and LAM. In order to narrow-down the potential causes for this discrepancy,
experiments that measure other inflammatory products must be explored.
Tuberculosis is a Bio-Safety Level 3 pathogen and it requires extreme caution and a
negative airflow laboratory when cultured. Given the elevated risk, LAM from Mycobacterium
smegmatisis utilized as a non-pathogenic model and substitute for LAM from Mtb.
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Lipoarabinomannan from M. smegmatisis also accessible and practical for use in the lab. The
LAM found in both Mtb and M. smegmatisis identical, except for capping variations that can
occur in some strains of each species (Fig. 3) (Mishra et al. 2011). Without the capping
molecules, the base structure for LAM of Mtb and M. smegmatisis identical.
An inevitable constraint encountered in all medical research is the ethics of testing and
validating new technologies. In order to avoid breaching medical ethics, non-human animal and
cellular models are often developed to take the place of what would otherwise need to be
human-derived. A murine macrophage model has been developed as one standard for research on
these monocytes. The RAW 264 cell line was established from tumors in mice with Abelson
leukemia virus (Raschke et al. 1978). The strain of macrophages is immortal, meaning it can be
maintained for an extended period of time by regularly transferring a sample of the cells to a new
flask and replenishing nutrients. This enables the experimenters to perform multiple experiments
on one original batch of cells. Specifically, the RAW 264.7 cell line has a well-established
response to LPS and can be used to observe production of NO, iNOS, and TNF-α in response to
bacterial infection. While human macrophages do not produce identical levels of NO, the murine
macrophages serve as an effective model of human macrophage activity.

8

Figure 3: Structures of lipoarabinomannan and related glycoconjugates from the cell envelope of
M. tuberculosis,M. smegmatis,and C. glutamicum. The black boxes indicate LAM variations in
both M. tuberculosis (left) and M. smegmatis (right), identical except for their capping. The
LAM found in M. tuberculosis is capped with mannose residues, making it Man-LAM. The
LAM found in M. smegmatisis capped with phosphate (gray) and inositol (blue), making if
PI-LAM (Adapted from Mishra et al. 2011).

The purpose of the study was to determine if RAW 264.7 murine macrophage activity
could be facilitated and intensified by stimulation with LAM from M. smegmatis.The
downstream effect is the production of inflammatory mediators, including NO and cytokines.
The product observed was NO, quantified with the Greiss assay which measures the stable
intermediate, nitrite. The expected results would indicate a dose-related response after
stimulation with LAM from M. smegmatis.These levels were compared to the stimulation with
LPS from E. coli, the positive control. If there is a significant difference in response levels from
the two compounds, the signal transduction pathways connected to Toll-like receptors for both
bacterial components will be explored in an attempt to identify the best method for measuring
macrophage response to LAM.
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MATERIALS AND METHODS
Cell Culture
The RAW 264.7 cells (ATCC; Manassas, VA) were cultured in DMEM complete, a
solution containing DMEM with 4.5 g/L glucose and L-glutamine (Lonza/BioWhittaker;
Walkersville, MD), 10% fetal bovine serum (Atlanta Biological, Lot#K13145; Flowery Branch,
GA), NaCO3 (Sigma-Aldrich;
St. Louis, MO), and penicillin/streptomycin (Sigma-Aldrich; St.

Louis, MO). Cells were grown in 25 cm2plastic flasks (CellTreat Scientific Products; Pepperell,
MA) in an incubator (Shel Labs; Cornelius, OR) under the following conditions: 37°C, 5% CO2,
and 90% humidity. Passage of the cells occurred every 4 days by scraping and transferring to 5
mL of fresh media, maintaining a 1:20 cells to media ratio. The cells were stained with trypan
blue and counted using a hemocytometer prior to each experiment in order to determine viability
and cells per unit volume.
LAM Treatment
All experiments were performed between passes 5-20. In order to achieve a cell
concentration of 0.8x106cells/mL, the appropriate volume of DMEM complete was added. A
24-well tissue culture plate (Costar Corning; Kennebunk, ME) was used and 500 μL of the cell
suspension was aliquoted to each well, yielding 4.0x105cells/well. After 12-16 hours of
incubation, the wells were washed twice with 500 μL DMEM. The LAM utilized in this
experiment was derived from Mycobacterium smegmatis(InvivoGen; San Diego, CA) at a stock
concentration of 0.33 μg/mL. The LPS used was from Escherichia coli,strain O55:B5
(Sigma-Aldrich; St. Louis, MO) and the stock concentration was 5 mg/mL. Treatment with LAM
occurred in the following concentrations: 0 ng/mL, 1 ng/mL, 10 ng/mL, 100 ng/mL, 1000 ng/mL
and 100 ng/mL LPS as a positive control. In order to maximize LAM response, an alternative
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dose response experiment was executed at the following LAM concentrations: 0 ng/mL, 100
ng/mL, 1000 ng/mL, 3000 ng/mL, 5000 ng/mL, and 100 ng/mL LPS. All 24-well plates were
incubated 24 hours following the addition of LAM or LPS for the induction of NO.
Greiss Assay
Sodium nitrite was used to create a standard curve of 1 μM to 125 μM nitrite along two
duplicate rows in a 96-well plate. The treated 24-well plate was retrieved from the incubator and
centrifuged for 2 minutes at 1000 rpm to remove any cell material from the supernatant. The
layout of each 24-well plate was replicated by transferring 50 μL of supernatant from each
treated well. The Greiss reagent was comprised of a 1:1 mixture of 1% sulfanilamide in 2.5%
phosphoric acid and 0.1% napthylethylenediamene dihydrochloride in 2.5% phosphoric acid.
Each well received 100 μL of the Greiss reagent. After about five minutes, a microplate reader
(BioTek Epoch with Gen 5 software, BioTek Instruments Inc.; Winooski, VT) recorded the
absorbance of each well at 550 nm and the results were exported to a spreadsheet. The standard
curve from sodium nitrite was used to determine the nitrite concentrations of experimental
samples. Each treatment was done in four replicate wells and these values were averaged.
Protein Isolation
A 200 μL sample was removed from each sample well of the 24-well plate to be frozen
(at -80°C) for future cytokine analysis. Then total protein was collected from each well to be
used for western blotting. The RIPA mixture was made using 3 mL RIPA buffer (with triton
X-100; Boston Bioproducts; Worcester, MA), 15 μL bovine lung Aprotinin (Sigma-Aldrich; St.
Louis, Missouri), 15 μL Sigma P8340 protease inhibitor cocktail (Sigma-Aldrich; St. Louis,
Missouri), and 6 μL 0.5M EDTA (Sigma-Aldrich; St. Louis, Missouri). Each well was washed
twice with 500 μL PBS (calcium/magnesium-free phosphate buffered saline; Sigma-Aldrich; St.
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Louis, Missouri) and received 100 μL of the RIPA mixture. After five minutes, a pipette tip was
used to scrape and triturate each well. All four wells containing the same treatment concentration
were consolidated into an individual microcentrifuge tube (USA Scientific; Orlando, FL), all of
which were stored in the -80°C freezer.
Bradford Assay
A protein standard curve was created using five stepwise dilutions from 2mg/mL Bovine
Serum Albumin (BSA; Sigma-Aldrich; St. Louis, Missouri). The dilutions of 5, 10, 20, 40, and
80 μg BSA were placed in a 96-well plate in 200 μL aliquots across the top row. In the second
row, 1 μL samples from the isolated RAW 264.7 proteins were inserted into 159 μL diH2O. Each
well containing sample received 40 μL of Bradford reagent (BioRad Laboratories; Hercules,
CA). The liquids were triturated to ensure thorough color dispersion. Trituration was performed
to ensure the Coomassie Blue interacted and bonded with the proteins. The plate was inserted
into the BioTek microplate reader and absorbance was measured at 595 nm. The standard curve
from BSA was used to determine the protein concentrations of experimental samples.
Statistical Analysis
Using SSPS (Ver. 25.0; IBM Corp.; Armack, NY, USA), the results were analyzed in a
one-way ANOVA test. This was used to determine significant differences between LAM dose
responses. A post-hoc analysis using a two-sided Dunnett’s t-test was performed to identify
significance from the negative control, 0 ng/mL LAM. Significance occurred when P ≤ 0.05.
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RESULTS
The RAW 264.7 macrophages were treated with LAM and LPS over a 24-hour window
and the nitrite concentration was measured with a Greiss assay. In the initial experiment, the 1.0
ng/mL, 10 ng/mL, and 100 ng/mL LAM conditions did not exceed 5 μM nitrite and were not
significantly different than the concentration of nitrite in the negative control (Fig. 4). The 1000
ng/mL LAM response averaged 6.1 μM nitrite. The 100 ng/mL LPS positive control reached a
nitrite concentration of 52.1 μM (Fig. 4). Significance occurred only in the LPS positive control
and not in any LAM treatments (Appendix A). Given the low levels yielded by LAM treatment
in experiment 1, an additional protocol was developed to include doses of higher concentrations.
In experiment 2, the 1.0 ng/mL and 10 ng/mL treatments were replaced with 3000 ng/mL
and 5000 ng/mL. The macrophages universally achieved increased output of NO as the nitrite
concentration reached 12.9 μM in the 1000 ng/mL LAM dose. The 3000 ng/mL and 5000 ng/mL
LAM treatments produced responses of 21.6 μM and 38.1 μM nitrite, respectively (Fig. 5). In
this experiment, the positive control produced 72.7 μM nitrite in response to 100 ng/mL LPS.
Only the 100 ng/mL LAM treatment was not significant when compared to the negative control
(Appendix B). Two repetitions with the treatments 100-5000 ng/mL LAM showed similar
responses. However, all conditions in experiment 3 yielded lower nitrite concentrations (Fig. 6).
The results of the 100 ng/mL and 1000 ng/mL LAM doses were not statistically significant
(Appendix C). The 3000 ng/mL and 5000 ng/mL LAM treatments, as well as 100 ng/mL LPS,
showed significance from the negative control (Appendix C).
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Figure 4: Preliminary stimulation of RAW 264.7 murine macrophages with LAM derived from
M. smegmatis. Initial dose response experiment measured by Greiss reaction used treatments of
1.0-1000 ng/mL LAM (blue bars). Negative and positive controls were 0 ng/mL LAM and 100
ng/mL LPS (orange bar), respectively. Absorbance recorded at 550 nm. The bars represent the ±
standard deviation among the four treatment wells. *P ≤ 0.05 in one-way ANOVA with
Dunnett’s post-hoc t-test analysis.
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Figure 5: Experiment 2 of RAW 264.7 murine macrophages stimulated with LAM derived from
M. smegmatis. Dose response experiment measured by Greiss reaction used treatments of
100-5000 ng/mL LAM (blue bars). Negative and positive controls were 0 ng/mL LAM and 100
ng/mL LPS (orange bar), respectively. Absorbance recorded at 550 nm. The bars represent the ±
standard deviation among the four treatment wells. *P ≤ 0.05 in one-way ANOVA with
Dunnett’s post-hoc t-test analysis.
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Figure 6: Experiment 3 of RAW 264.7 murine macrophages stimulated with LAM derived from
M. smegmatis. Dose response experiment measured by Greiss reaction used treatments of
100-5000 ng/mL LAM (blue bars). Negative and positive controls were 0 ng/mL LAM and 100
ng/mL LPS (orange bar), respectively. Absorbance recorded at 550 nm. The bars represent the ±
standard deviation among the four treatment wells. *P ≤ 0.05 in one-way ANOVA with
Dunnett’s post-hoc t-test analysis.
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DISCUSSION
The purpose of this study was to determine if RAW 264.7 murine macrophages would
show dose-responsive activity when treated with LAM derived from M. smegmatis.It was
predicted that the interaction of LAM with the TLR-2 signaling pathway would increase NO
output, and ultimately nitrite concentration, when dosed with increasing concentrations of LAM.
The positive control of LPS from E. coliwas used to determine if the magnitude of LAM
response was comparable to a common standard. The results indicate that LAM can stimulate a
dose-dependent, inflammatory response in murine macrophages.
In a previous report, Zaman (2019) conducted two congruent trials similar to those in this
study. Her preliminary experiment, compatible with experiment 1, showed significance at the
100 ng/mL and 1000 ng/mL LAM doses, yielding approximately 8 μM and 55 μM nitrite
respectively (Zaman 2019). There was also significance in the 100 ng/mL LPS control which
produced approximately 104 μM (Zaman 2019). The second experiment performed by Zaman
(2019) was identical to experiment 2 in this investigation, with the addition of 10 ng/mL and
2000 ng/mL LAM treatments. A dose-response effect of LAM was observed between 1000 and
5000 ng/mL and was determined to be significantly different from untreated controls (Zaman
2019). Her data indicates a response of approximately 65 μM nitrite in the 5000 ng/mL LAM
treatment, while the data from experiments 2 and 3 here show only 38.1 μM and 27.5 μM nitrite
respectively. While similar trends exist between the two studies, the results of Zaman (2019) far
exceeded the output of NO found in the data of this report. A potential explanation for these
discrepancies could be the less than ideal growth conditions the RAW cells experienced due to
damaged incubators. Despite the fact that this study yielded lower responses, the dose-response
trends are analogous to those found by Zaman (2019) and show that LAM can induce
dose-related NO production in RAW 264.7 murine macrophages. The results are in accordance
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with other sources that indicate RAW cell stimulation with LAM can produce a NO response
(Park et al. 2000).
After analyzing the data of all three experiments, adjacent with those of Zaman (2019), it
is evident that the RAW 264.7 murine macrophages are not as sensitive to LAM as they are LPS.
There are several possibilities to explain this phenomenon, some of which refer to the different
receptors through which each compound interacts with the macrophage. Since TLRs each bind
with unique ligands, the difference could be a result of LPS interacting with TLR-4 and LAM
with TLR-2. While it is difficult to find research on specific affinities of TLRs, it is likely that
they fluctuate among the TLRs, potentially causing the response difference of LAM and LPS.
The quantity of each TLR on the surface of the macrophage could also play a role in the level of
response. If the presence of TLR-4 is far greater than that of TLR-2, it would be expected to see
a diminished activation of the macrophages when treated with LAM. Additional research should
be conducted in order to examine the effect of supplementary molecules on the NO production of
macrophages.
Limitations encountered when conducting this research included both local and global
disruptions. Due to the halted and incomplete renovation of laboratory facilities, research that
should have commenced in August of 2019, did not begin until January of 2020. At the end of
February, the primary cell culture incubator suffered a thermostat malfunction, causing
temperature regulation to fail. An alternative incubator was set up for use and the cells were
transferred. This incubator, however, did not maintain proper humidity because of inconsistent
CO2regulation. Finally, March brought with it the news that classes would resume online after
Spring break as a result of the COVID-19 outbreak. This prevented further experimentation
which would have augmented the presented data. These protocols would have included using
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ELISA for quantification of TNF-α and western blot analysis of iNOS. The original intentions of
this study were to compare the relative NO output to the presence of both TNF-α and iNOS. If
the research is to be continued, one could compare the TLR-4 and TLR-2 pathways, exploring
the impact they have on the output of NO and pro-inflammatory cytokines.
The results of the present study contribute on a small scale to the overall knowledge of
interactions between LAM and macrophages. By knowing the extent at which LAM activates
macrophage production of NO, scientists can begin to grasp the downstream effects of Mtb
invasion. Research shows that pathogenic mycobacterial LAM acts as an intercalating agent that
stunts phagosomal maturation (Guenin-Macé et al. 2009). Additionally, LAM from Mtbinhibits
the production of pro-inflammatory cytokines, such as IL-12, preventing the development of
other critical immune cells (Guenin-Macé et al. 2009). A thorough understanding of the
molecular pathways of infection is vital for the improvement of TB treatments and medication.
Given the continued severity and prevalence of the disease, the diagnosis and treatment of the
disease has never been more crucial. Research in this field must continue in an attempt to more
effectively target the processes which make the infection so virulent.
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APPENDIX A
Statistical analysis of experiment 1 and the data represented in Figure 4. One-way ANOVA with
Dunnett’s host-hoc t-test analysis. Significance indicated when P ≤ 0.05.

Oneway
ANOVA
LAM Data
Sum of Squares
Between Groups
Within Groups
Total

df

Mean Square

F

7334.461

5

1466.892

104.715

18

5.817

7439.176

23

Sig.

252.152

.000

Post Hoc Tests
Multiple Comparisons
Dependent Variable: LAM Data
Dunnett t (2-sided)a
Mean

95% Confidence Interval

(I) V1

(J) V1

1

6

-.54750

1.70551

.997

-5.2571

4.1621

2

6

-.77000

1.70551

.988

-5.4796

3.9396

3

6

-1.22750

1.70551

.921

-5.9371

3.4821

4

6

1.45500

1.70551

.860

-3.2546

6.1646

5

6

46.63500*

1.70551

.000

41.9254

51.3446

Difference (I-J)

Std. Error

Sig.

Lower Bound

Upper Bound

*. The mean difference is significant at the 0.05 level.
a. Dunnett t-tests treat one group as a control, and compare all other groups against it.
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APPENDIX B
Statistical analysis of experiment 2 and the data represented in Figure 5. One-way ANOVA with
Dunnett’s host-hoc t-test analysis. Significance indicated when P ≤ 0.05.

Oneway
ANOVA
LAM data
Sum of Squares
Between Groups

Mean Square

F

14234.493

5

2846.899

37.604

18

2.089

14272.097

23

Within Groups
Total

df

Sig.

1362.747

.000

Post Hoc Tests
Multiple Comparisons
Dependent Variable: LAM data
Dunnett t (2-sided)a
Mean

95% Confidence Interval

(I) V1

(J) V1

1

6

.41000

1.02203

.993

-2.4122

3.2322

2

6

10.00000*

1.02203

.000

7.1778

12.8222

3

6

18.67500*

1.02203

.000

15.8528

21.4972

4

6

35.20250*

1.02203

.000

32.3803

38.0247

5

6

69.74750*

1.02203

.000

66.9253

72.5697

Difference (I-J)

Std. Error

Sig.

Lower Bound

Upper Bound

*. The mean difference is significant at the 0.05 level.
a. Dunnett t-tests treat one group as a control, and compare all other groups against it.
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APPENDIX C
Statistical analysis of experiment 3 and the data represented in Figure 6. One-way ANOVA with
Dunnett’s host-hoc t-test analysis. Significance indicated when P ≤ 0.05.

Oneway
ANOVA
LAM/LPS μM Concentration
Sum of Squares
Between Groups

Mean Square

F

13283.182

5

2656.636

33.614

18

1.867

13316.796

23

Within Groups
Total

df

Sig.

1422.596

.000

Post Hoc Tests
Multiple Comparisons
Dependent Variable: LAM/LPS μM Concentration
Dunnett t (2-sided)a
Mean

95% Confidence Interval

(I) V1

(J) V1

1

6

.20000

.96630

1.000

-2.4683

2.8683

2

6

1.47250

.96630

.433

-1.1958

4.1408

3

6

8.45500*

.96630

.000

5.7867

11.1233

4

6

26.47250*

.96630

.000

23.8042

29.1408

5

6

65.43250*

.96630

.000

62.7642

68.1008

Difference (I-J)

Std. Error

Sig.

Lower Bound

Upper Bound

*. The mean difference is significant at the 0.05 level.
a. Dunnett t-tests treat one group as a control, and compare all other groups against it.

